[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group name:Arm 1 Type of group;1 N\u00b0 of participants:90 Intervention(s) description:\u2022\tGroup 1 (6 mcg dose of CVnCoV vaccine (COVID-19 vaccine)). This group of people; from 18 to 60 years of age; will receive a 6-mcg dose of the vaccine on Day 1 and on Day 29 of the study.\t\t\t\tSubject Follow up Time:\t180 days (booster dose)\t\t\t\tGroup name:Arm 6 Type of group;2 N\u00b0 of participants:12 Intervention(s) description:\u2022Group 6 (control group with the pneumococcal vaccine). This group of people; 61 years of age and older; will receive an injection with the pneumococcal control vaccine on Day 1 and Day 29 of the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "1 or 2", "treatment_id": 568, "treatment_name": "Hepatitis a vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "1 or 2", "treatment_id": 1006, "treatment_name": "Pneumococcal vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "6 mcg;1 or 2;18 to 60 years vs 61 years of age and older", "treatment_id": 364, "treatment_name": "Cvncov", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "8 mcg;1 or 2;61 years of age and older", "treatment_id": 364, "treatment_name": "Cvncov", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group name:Arm 1 Type of group;1 N\u00b0 of participants:90 Intervention(s) description:\u2022\tGroup 1 (6 mcg dose of CVnCoV vaccine (COVID-19 vaccine)). This group of people; from 18 to 60 years of age; will receive a 6-mcg dose of the vaccine on Day 1 and on Day 29 of the study.Subject Follow up Time:\t180 days (booster dose)Group name:Arm 6 Type of group;2 N\u00b0 of participants:12 Intervention(s) description:\u2022Group 6 (control group with the pneumococcal vaccine). This group of people; 61 years of age and older; will receive an injection with the pneumococcal control vaccine on Day 1 and Day 29 of the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]